© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Establishment Labs Holdings Inc. (ESTA) stock surged +1.69%, trading at $93.48 on NASDAQ, up from the previous close of $91.93. The stock opened at $93.38, fluctuating between $92.71 and $94.40 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 30, 2026 | 93.72 | 94.40 | 92.67 | 93.48 | 454.76K |
| Jul 29, 2026 | 91.10 | 94.26 | 89.38 | 91.93 | 479.21K |
| Jul 28, 2026 | 92.31 | 94.90 | 90.51 | 91.90 | 366.96K |
| Jul 27, 2026 | 93.70 | 94.68 | 90.95 | 92.10 | 367.06K |
| Jul 24, 2026 | 92.30 | 94.05 | 90.71 | 92.32 | 207.63K |
| Jul 23, 2026 | 92.72 | 94.57 | 91.04 | 91.10 | 547.82K |
| Jul 22, 2026 | 95.35 | 95.80 | 93.27 | 93.87 | 299K |
| Jul 21, 2026 | 93.50 | 96.99 | 92.30 | 95.65 | 635.61K |
| Jul 20, 2026 | 92.58 | 94.58 | 92.08 | 93.42 | 644.28K |
| Jul 17, 2026 | 91.35 | 92.86 | 89.59 | 92.58 | 464.55K |
| Jul 16, 2026 | 90.62 | 93.12 | 89.91 | 92.30 | 389.13K |
| Jul 15, 2026 | 89.49 | 90.84 | 86.10 | 90.62 | 365.07K |
| Jul 14, 2026 | 87.75 | 87.75 | 83.85 | 86.59 | 317.61K |
| Jul 13, 2026 | 88.03 | 88.97 | 86.42 | 87.90 | 299.81K |
| Jul 10, 2026 | 89.96 | 90.19 | 86.08 | 88.03 | 271.51K |
| Jul 09, 2026 | 88.82 | 89.97 | 86.92 | 88.77 | 285.3K |
| Jul 08, 2026 | 88.14 | 90.00 | 86.13 | 87.99 | 661.44K |
| Jul 07, 2026 | 91.09 | 92.67 | 88.00 | 91.04 | 669.22K |
| Jul 06, 2026 | 89.50 | 92.84 | 89.03 | 91.56 | 806.83K |
| Jul 02, 2026 | 90.48 | 90.48 | 87.90 | 89.25 | 440.02K |
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
| Employees | 1004 |
| Beta | 1.07 |
| Sales or Revenue | $165.15M |
| 5Y Sales Change% | 0.829% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |